Current location:Worldly Workshop news portal > style
Lilly rides Mounjaro, Zepbound to better
Worldly Workshop news portal2024-05-01 04:59:45【style】2People have gathered around
IntroductionRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Address of this article:http://azerbaijan.nashville-west.com/article-26c599409.html
Very good!(739)
Related articles
- Democrats vow to protect Speaker Mike Johnson from being ousted from office
- The Making of China's Olympic Mascots
- Helping Design China's First Large Passenger Aircraft
- Fu Qiaomei Becomes First Chinese Scientist to Win UNESCO
- What's causing the catastrophic rainfall in Kenya?
- China's Chen, Quan Finish 1
- Young Policewoman Fulfils Her Passion as Police Dog Trainer
- Feature: ALS Sufferer Inspires Others with 15,000
- HSBC CEO Noel Quinn plans to retire
- China's Chen, Wang Lift Women's Doubles Trophy at Durban Table Tennis Worlds
Popular articles
Recommended
Moment serial dine
Li Bingjie Wins Women's 400m Freestyle at Hangzhou Asiad
Li Hongfeng Wins Gold of Women's Cross Country Olympic of Cycling Mountain Bike at Hangzhou Asiad
China's Teenager Zheng Dominates Local Favorite to Reach Last 16 at French Open
The cancer drugs that could improve survival rates if given to patients in the morning
Hard Work, Many Revisions Made Paralympic Mascot
China's Talent Pool Goes for Glory
Enjoying Breathtaking Winter Landscapes
Links
- New UK sanctions targeting Chinese companies over Ukraine crisis are unilateralism:embassy
- Xi stresses promoting equipment renewal, trade
- China making its mark in global services trade
- Hayao Miyazaki's animated fantasy leads Chinese box office
- Multinationals committed to China
- Forum highlights structural reforms
- Xi sends congratulatory message to 37th AU Summit
- China, Republic of Congo mark 60th anniversary of ties
- Beijing International Film Festival to feature French film week
- Across China: Chinese people pay tributes to legendary ancestor